Release Date: 15/10/14 14:15 Summary: Austin Completes Bridging Facility Price Sensitive: Yes Download Document 201.15KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%